Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle

Bohrmann, 2012, Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β, J. Alzheimers Dis., 28, 49, 10.3233/JAD-2011-110977 Crépin, 2010, Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas, Cancer Res., 70, 5497, 10.1158/0008-5472.CAN-10-0938 Gosk, 2004, Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion, J. Cereb. Blood Flow Metab., 24, 1193, 10.1097/01.WCB.0000135592.28823.47 Kozik, 2013, A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase, Nat. Cell Biol., 15, 50, 10.1038/ncb2652 Lakadamyali, 2006, Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes, Cell, 124, 997, 10.1016/j.cell.2005.12.038 LaVaute, 2001, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nat. Genet., 27, 209, 10.1038/84859 Lesley, 1989, Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments, Exp. Cell Res., 182, 215, 10.1016/0014-4827(89)90293-0 Levy, 1999, Transferrin receptor is necessary for development of erythrocytes and the nervous system, Nat. Genet., 21, 396, 10.1038/7727 Liu, 2010, Local clustering of transferrin receptors promotes clathrin-coated pit initiation, J. Cell Biol., 191, 1381, 10.1083/jcb.201008117 Matsui, 2011, Small GTPase Rab12 regulates constitutive degradation of transferrin receptor, Traffic, 12, 1432, 10.1111/j.1600-0854.2011.01240.x Michel, 2013, Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion, Int. J. Cancer, 132, E1, 10.1002/ijc.27811 Mielke, 2012, Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology, 79, 1570, 10.1212/WNL.0b013e31826e2696 Navaroli, 2012, Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis, Proc. Natl. Acad. Sci. USA, 109, E471, 10.1073/pnas.1115495109 Pardridge, 2012, Drug transport across the blood-brain barrier, J. Cereb. Blood Flow Metab., 32, 1959, 10.1038/jcbfm.2012.126 Pardridge, 2012, Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier, Methods Enzymol., 503, 269, 10.1016/B978-0-12-396962-0.00011-2 Paris-Robidas, 2011, In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor, Mol. Pharmacol., 80, 32, 10.1124/mol.111.071027 Poduslo, 1994, Macromolecular permeability across the blood-nerve and blood-brain barriers, Proc. Natl. Acad. Sci. USA, 91, 5705, 10.1073/pnas.91.12.5705 Richards, 2003, PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation, J. Neurosci., 23, 8989, 10.1523/JNEUROSCI.23-26-08989.2003 Staquicini, 2011, Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma, J. Clin. Invest., 121, 161, 10.1172/JCI44798 Sumbria, 2013, Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice, Mol. Pharm., 10, 1425, 10.1021/mp400004a Wang, 2013, Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier, Proc. Natl. Acad. Sci. USA, 110, 2999, 10.1073/pnas.1222742110 Weksler, 2005, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J., 19, 1872, 10.1096/fj.04-3458fje Yu, 2011, Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target, Sci. Transl. Med., 3, 84ra44, 10.1126/scitranslmed.3002230